PCM
LKFT

Peregrine Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Peregrine Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-410
Closed -$41K – 347
2020
Q4 		$41K Sell
410
-31,333
-99% -$3.83M ﹤0.01% 293
2020
Q3 		$4.5M Sell
31,743
-3,116
-9% -$520K 0.12% 238
2020
Q2 		$6.88M Sell
34,859
-5,124
-13% -$1.06M 0.2% 157
2020
Q1 		$7.83M Sell
39,983
-23,461
-37% -$5.05M 0.28% 126
2019
Q4 		$13.1M Sell
63,444
-7,998
-11% -$1.48M 0.33% 126
2019
Q3 		$10.9M Sell
71,442
-4,706
-6% -$771K 0.3% 136
2019
Q2 		$9.82M Sell
76,148
-8,752
-10% -$1.04M 0.24% 157
2019
Q1 		$10M Sell
84,900
-1,758
-2% -$177K 0.25% 153
2018
Q4 		$7.95M Sell
86,658
-569
-0.7% -$57.7K 0.22% 166
2018
Q3 		$9.81M Sell
87,227
-20,448
-19% -$2.16M 0.23% 154
2018
Q2 		$9.93M Buy
107,675
+5,539
+5% +$537K 0.25% 142
2018
Q1 		$10.2M Sell
102,136
-15,075
-13% -$1.62M 0.25% 145
2017
Q4 		$11M Buy
117,211
+10,617
+10% +$1M 0.26% 152
2017
Q3 		$10.8M Sell
106,594
-7,805
-7% -$682K 0.26% 158
2017
Q2 		$8.75M Sell
114,399
-650
-0.6% -$54.7K 0.22% 200
2017
Q1 		$9.88M Sell
115,049
-18,764
-14% -$1.35M 0.25% 162
2016
Q4 		$8.59M Buy
+133,813
New +$8.23M 0.22% 210

Other funds holding LKFT

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Peregrine Capital Management's LKFT Position: Q1 2021 in Review

Peregrine Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2021, closing a stake of 410 shares — an estimated $41K sold.

Peregrine Capital Management first reported a position in LKFT in Q4 2016 and held it in 17 quarters. The position peaked at $13.1M in Q4 2019. 132 funds tracked by Wall St. Rank hold LKFT as of Q1 2021.

  • Peregrine Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Peregrine Capital Management sold 410 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2021, an estimated $41K.
  • Peregrine Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2016 and held it in 17 quarters.
  • Peregrine Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $13.1M in Q4 2019.
  • 132 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2021.

Based on Peregrine Capital Management's 13F filing for Q1 2021, filed 11 May 2021.